Ohio Public Employees Retirement System (OPERS)’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-132,688
Closed -$216K 2316
2025
Q3
$216K Buy
+132,688
New +$259K ﹤0.01% 1661

Other funds holding AUTL

Ohio Public Employees Retirement System (OPERS)'s AUTL Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Autolus Therapeutics (AUTL) in Q4 2025, closing a stake of 132,688 shares — an estimated $216K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in AUTL in Q3 2025 and held it in 1 quarter. The position peaked at $216K in Q3 2025. 89 funds tracked by Wall St. Rank hold AUTL as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Autolus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 132,688 Autolus Therapeutics shares in Q4 2025, an estimated $216K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Autolus Therapeutics in Q3 2025 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s Autolus Therapeutics position peaked at $216K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.